About this event
Global clinical trials depend on one constant: every participant, in every country, must understand what’s being asked of them. Every error introduced during translation or migration creates downstream delays, more proofreading cycles, and ultimately, slower patient access.
In this webinar, Jonathan Norman, Director of Localization at YPrime, and Dr. Karl McEvoy, Vice President, eCOA and Patient Technologies at YPrime, will discuss new research first presented at ISPOR that explores how AI enhances the accuracy of eCOA localization. Drawing on results from a 15-study analysis, discover how AI-powered migration process reduces human error, accelerates approvals, and supports more inclusive, globally representative clinical trials.
Attendees will gain a clear understanding of how AI can—and should—be applied to the localization process without compromising linguistic or regulatory integrity.
Target Audience
Register Today!
Hosted by
With 9 years of experience in localizing paper and electronic COAs, Jonathan today leads translation and questionnaire licensing strategies for YPrime. He develops innovative approaches to ensure quality and accuracy in translated clinical trial materials, focusing on reducing translation burdens and increasing trial diversity. Throughout his career, Jonathan has progressed from Project Manager to Director roles in linguistic validation and quality assurance. He's a trusted SME in localization best practices, maintaining strong relationships with eCOA providers, pharma sponsors, and copyright holders across the clinical research industry.
Karl is an accomplished scientist and business leader who has led global projects with an emphasis on patient-centered outcomes across a diverse range of diseases and therapeutic areas. He has more than 14 years’ experience in clinical research, having worked for pharmaceutical companies/sponsors, as well as clinical technology providers. He has working knowledge of eCOA, eConsent, translations, licensing, and library management. Karl serves as the current Industry Co-Director for the Critical Path Institute (C-Path) eCOA Consortium for the 2024/2025 and 2025/2026 terms. He obtained a BSc (honors) degree in Industrial Microbiology, and later a PhD in Neuroscience from University College Dublin, with his doctoral work focused on the Prion protein and its role in neurodegeneration.
Livestorm is a software company that provides a browser-based online web conferencing software for webinars and virtual meetings. Livestorm is the end-to-end video engagement platform enabling organizations to create on-demand, live, or pre-recorded ev...
